Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01774-X/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_easd25&_hsenc=p2ANqtz-_ugaRCYE2EIpLkC0lr_zhpFqxgJY9YNzqXpdyijBpMIYzyq2mJnK9FEe3nCq90PPN-rwRlACnSr_VcJ0hRlFjPW7FwnQ&_hsmi=380999091&utm_content=380999091&utm_source=hs_email